About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | The Evolution and Management of Migraine Recurrence Beyond 24 Hours

The Evolution and Management of Migraine Recurrence Beyond 24 Hours

NCT00754611·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Rowan University

With

Endo USA Inc., a Keenova Therapeutics Company

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Female and male patients at University Headache Center with \> 6 month diagnosis of migraine with and/or without aura (ICHD-II)
Greater than or equal to 18 years old

You may not be if

Greater than 15 days/month total headache days
Analgesic use greater than 15 days/month (other than aspirin less than or equal to 325mg/d)

The record

StatusCompleted

PhaseNo phase

Taking part100

StartedDec 2008

UpdatedOct 28, 2019

Conditions

Where1

University of Medicine and Dentistry of New Jersey
Stratford, New Jersey, United States